Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 33.42% is 1162% above its 5-year average of -3.15%, around the middle of its 5-year range (-97.91%–96.33%).
16.24% above its 12-month average of 28.75%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 10.23%.
NET PROFIT MARGIN
33.42%
NET PROFIT MARGIN AVG TTM
28.75%
NET PROFIT MARGIN AVG 3Y
11.06%
NET PROFIT MARGIN AVG 5Y
-3.15%
NET PROFIT MARGIN AVG 10Y
-45.57%
NET PROFIT MARGIN AVG 15Y
-308.23%
NET PROFIT MARGIN AVG 20Y
-392.98%
CURRENT VS TTM AVG
+16.24%
CURRENT VS 3Y AVG
+202.11%
CURRENT VS 5Y AVG
+1162.36%
CURRENT VS 10Y AVG
+173.33%
CURRENT VS 15Y AVG
+110.84%
CURRENT VS 20Y AVG
+108.50%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 729 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Acadia Pharmaceuticals Inc.
Market Cap
$3.42B
Net Profit Margin
33.42%
TTM Avg
28.75%
3Y Avg
11.06%
5Y Avg
-3.15%
Market Cap
$3.43B
Net Profit Margin
-6755.78%
TTM Avg
-10397.28%
3Y Avg
-7288.11%
5Y Avg
-5606.97%
Market Cap
$3.34B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.53B
Net Profit Margin
-74.75%
TTM Avg
-1986.54%
3Y Avg
-1142.83%
5Y Avg
-820.99%
Market Cap
$3.53B
Net Profit Margin
-1.69%
TTM Avg
-12.55%
3Y Avg
-19.61%
5Y Avg
-21.06%
Market Cap
$3.58B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.14B
Net Profit Margin
-14191.20%
TTM Avg
0.00%
3Y Avg
-86.13%
5Y Avg
-153.41%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc. (ACAD) | $3.42B | 33.42% | 28.75% | 11.06% | -3.15% |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.43B | -6755.78% | -10397.28% | -7288.11% | -5606.97% |
| CareDx, Inc (CDNA)vs › | $3.41B | 24.23% | 5.06% | -20.39% | -16.94% |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.34B | 0.00% | 0.00% | 0.00% | 0.00% |
| Celcuity Inc. (CELC)vs › | $3.51B | 0.00% | 0.00% | 0.00% | 0.00% |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.53B | -74.75% | -1986.54% | -1142.83% | -820.99% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.53B | -1.69% | -12.55% | -19.61% | -21.06% |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.58B | 0.00% | 0.00% | 0.00% | 0.00% |
| Denali Therapeutics Inc. (DNLI)vs › | $3.14B | -14191.20% | 0.00% | -86.13% | -153.41% |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.07B | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
7.6%
Net Profit Margin
33.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 10.23% |
| 2026-03-31 | 1.36% |
| 2025-12-31 | 96.33% |
| 2025-09-30 | 25.76% |
| 2025-06-30 | 10.08% |
| 2025-03-31 | 7.77% |
| 2024-12-31 | 55.37% |
| 2024-09-30 | 13.09% |
| 2024-06-30 | 13.80% |
| 2024-03-31 | 8.04% |
| 2023-12-31 | 19.82% |
| 2023-09-30 | -30.79% |
| 2023-06-30 | 0.67% |
| 2023-03-31 | -36.32% |
| 2022-12-31 | -30.57% |
| 2022-09-30 | -20.80% |
| 2022-06-30 | -25.28% |
| 2022-03-31 | -97.91% |
| 2021-12-31 | -32.96% |
| 2021-09-30 | -10.98% |
| 2021-06-30 | -38.08% |
| 2021-03-31 | -62.36% |
| 2020-12-31 | -55.17% |
| 2020-09-30 | -70.21% |
| 2020-06-30 | -38.27% |
| 2020-03-31 | -97.73% |
| 2019-12-31 | -53.94% |
| 2019-09-30 | -44.38% |
| 2019-06-30 | -66.03% |
| 2019-03-31 | -135.49% |
| 2018-12-31 | -109.94% |
| 2018-09-30 | -106.57% |
| 2018-06-30 | -110.87% |
| 2018-03-31 | -111.11% |
| 2017-12-31 | -158.10% |
| 2017-09-30 | -183.39% |
| 2017-06-30 | -221.30% |
| 2017-03-31 | -574.66% |
| 2016-12-31 | -657.88% |
| 2016-09-30 | -1359.40% |
| 2016-06-30 | -73527.84% |
| 2016-03-31 | -1244050.00% |
| 2015-12-31 | -269317.65% |
| 2015-09-30 | -99758.97% |
| 2015-06-30 | -3937800.00% |
| 2015-03-31 | -1009375.00% |
| 2014-12-31 | -60353.19% |
| 2014-09-30 | -165240.00% |
| 2014-06-30 | -76767.86% |
| 2014-03-31 | -59426.67% |
| 2013-12-31 | -32564.86% |
| 2013-09-30 | -4456.25% |
| 2013-06-30 | -2013.53% |
| 2013-03-31 | -1468.35% |
| 2012-12-31 | -1792.11% |
| 2012-09-30 | -69.06% |
| 2012-06-30 | -904.67% |
| 2012-03-31 | -1381.78% |
| 2011-12-31 | -901.36% |
| 2011-09-30 | -869.18% |
| 2011-06-30 | -1425.22% |
| 2011-03-31 | -1340.92% |
| 2010-12-31 | 82.31% |
| 2010-09-30 | -183.70% |
| 2010-06-30 | -186.68% |
| 2010-03-31 | -257.24% |
| 2009-12-31 | -491.18% |
| 2009-09-30 | -358.44% |
| 2009-06-30 | -699.34% |
| 2009-03-31 | -4010.96% |
| 2008-12-31 | -4296.31% |
| 2008-09-30 | -5536.88% |
| 2008-06-30 | -10331.64% |
| 2008-03-31 | -2032.26% |
| 2007-12-31 | -1076.37% |
| 2007-09-30 | -819.88% |
| 2007-06-30 | -523.26% |
| 2007-03-31 | -640.51% |
| 2006-12-31 | -702.20% |
| 2006-09-30 | -579.67% |
| 2006-06-30 | -630.89% |
| 2006-03-31 | -373.16% |
| 2005-12-31 | -417.64% |
| 2005-09-30 | -335.00% |
| 2005-06-30 | -240.07% |
| 2005-03-31 | -240.38% |
| 2004-12-31 | -677.02% |
| 2004-09-30 | -393.00% |
| 2004-06-30 | -579.55% |
| 2004-03-31 | -701.50% |
| 2003-12-31 | -191.00% |
| 2003-09-30 | -191.00% |
| 2003-06-30 | -130.48% |
| 2003-03-31 | -184.39% |
